1-5 of 5
Erin Zagadailov, PharmD, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Durability of Response Reported in Refractory CTCL: A Systematic Review

Mehul R Dalal, PhD, Stephen Mitchell, PhD, Conor McCloskey, PhD, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5598.
https://doi.org/10.1182/blood.V130.Suppl_1.5598.5598
Published: 2017
Journal Articles

The Risk-Benefit Balance of Treatments for Hodgkin Lymphoma Reported in the Randomised and Non-Randomised Trial Setting: A Systematic Review

Mehul Dalal, PhD, Stephen Mitchell, PhD, Conor McCloskey, PhD, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5605.
https://doi.org/10.1182/blood.V130.Suppl_1.5605.5605
Published: 2017
Journal Articles

Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, Maral DerSarkissian, PhD, Mei Sheng Duh, MPH, ScD, Marie-Hélène Lafeuille, MA, George Posner, BA, Stephen Ralston, PhD, Erin Zagadailov, PharmD, MS, Abbie Ba-Mancini, MSc, MBA, Robert M Rifkin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5599.
https://doi.org/10.1182/blood.V130.Suppl_1.5599.5599
Published: 2017
Journal Articles

Patient and Physician Preferences for Front-Line Treatment of Advanced Stage Hodgkin Lymphoma in Germany, France and the United Kingdom

Paul Broeckelmann, Aspasia Stamatoullas, MD, Suzanne McMullen, Ben Wilson, MSc, Kerstin Mueller, MSc, MA, PhD, Sarah Goring, MSc, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD, Dirk Huebner, MD, Mehul Dalal, PhD, Tim M. Illidge, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4082.
https://doi.org/10.1182/blood.V130.Suppl_1.4082.4082
Published: 2017
Journal Articles

Brentuximab Vedotin Demonstrates Significantly Superior Clinical Outcomes in Patients with CD30-Expressing Cutaneous T Cell Lymphoma Versus Physician's Choice (Methotrexate or Bexarotene): The Phase 3 Alcanza Study

Youn H Kim, MD, Sean Whittaker, MB, ChB, FRCP, MD, Steven M Horwitz, MD, Madeleine Duvic, MD, Reinhard Dummer, MD, Julia J Scarisbrick, MBChB FRCP MD, Pietro Quaglino, MD, Pier Luigi Zinzani, MD PhD, Pascal Wolter, MD, Yinghui Wang, MS, Maria Corinna Palanca-Wessels, MD PhD, Erin Zagadailov, PharmD, MS, William L Trepicchio, PhD, Yi Liu, PhD, Meredith Little, MPH, H Miles Prince, MD
Journal: Blood
Blood (2016) 128 (22): 182.
https://doi.org/10.1182/blood.V128.22.182.182
Published: 2016